Cite

HARVARD Citation

    Cloyd, J. et al. (2019). The emerging role of targeted therapies for advanced well-differentiated gastroenteropancreatic neuroendocrine tumors. Expert review of clinical pharmacology. 12 (2), pp. 101-108. [Online]. 
  
Back to record